Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Q&A
Clinical Diagnostics
MRD: Market Reflections in Diagnostics - A Conversation with Mark Kaganovich, CEO of Tracer Biotechnologies
We sat down with Mark Kaganovich, CEO of Tracer Biotechnologies, to discuss how Tracer is advancing ctDNA detection and reshaping what’s possible in minimal residual disease (MRD) monitoring.
September 23, 2025
DeciBio Q&A
Clinical Diagnostics
MRD: Market Reflections in Diagnostics - A Conversation with Mark Kaganovich, CEO of Tracer Biotechnologies
We sat down with Mark Kaganovich, CEO of Tracer Biotechnologies, to discuss how Tracer is advancing ctDNA detection and reshaping what’s possible in minimal residual disease (MRD) monitoring.
September 23, 2025
MRD Testing
Blog Article
Research Tools
The Great Diagnostics Tension: Outsourcing vs. Decentralization
In this article, we share our perspective on decentralization based on internal DeciBio databases and tracker, layering the perspective of Joseph Annunziata, a KOL we interview for many of our engagements.
September 22, 2025
Blog Article
Research Tools
The Great Diagnostics Tension: Outsourcing vs. Decentralization
In this article, we share our perspective on decentralization based on internal DeciBio databases and tracker, layering the perspective of Joseph Annunziata, a KOL we interview for many of our engagements.
September 22, 2025
NGS
Diagnostics Market
life science research tools
Research Tools
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | August Round-Up 2025
Liquid Biopsy (LBx) continued to develop through August, featuring new product launches and partnerships as well as study results.
September 19, 2025
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | August Round-Up 2025
Liquid Biopsy (LBx) continued to develop through August, featuring new product launches and partnerships as well as study results.
September 19, 2025
Liquid Biopsy
Blog Article
Clinical Diagnostics
Rethinking Cancer Screening in Europe: The Promise and Peril of MCED Testing
Europe weighs the promise and pitfalls of multi-cancer early detection (MCED) tests as new launches spark debate over whether they can truly transform cancer screening.
September 17, 2025
Blog Article
Clinical Diagnostics
Rethinking Cancer Screening in Europe: The Promise and Peril of MCED Testing
Europe weighs the promise and pitfalls of multi-cancer early detection (MCED) tests as new launches spark debate over whether they can truly transform cancer screening.
September 17, 2025
EDx
Clinical Diagnostics
MCED
Newsletter Update
Financial Services
Investing in Precision Medicine: VC | PE | M&A - August Round-Up 2025
August 2025 marked an active period in life sciences, propelled by acquisitions and fundraising across biotech, pharma, and health tech.
September 17, 2025
Newsletter Update
Financial Services
Investing in Precision Medicine: VC | PE | M&A - August Round-Up 2025
August 2025 marked an active period in life sciences, propelled by acquisitions and fundraising across biotech, pharma, and health tech.
September 17, 2025
Precision Medicine
DeciBio Ventures
Private Equity
Webinar
Clinical Diagnostics
Tracking NGS Adoption in Oncology: Insights from Oncologists, Pathologists, and Industry Leaders Webinar
This webinar is a data-driven discussion on the current state of NGS in oncology and where adoption is headed next.
September 16, 2025
Webinar
Clinical Diagnostics
Tracking NGS Adoption in Oncology: Insights from Oncologists, Pathologists, and Industry Leaders Webinar
This webinar is a data-driven discussion on the current state of NGS in oncology and where adoption is headed next.
September 16, 2025
Research Tools
Immuno-Oncology
Clinical Diagnostics
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved